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Abstract
Introduction: The caspase recruitment domain containing protein 9 (CARD9) deficiency is a primary immunodeficiency disorder
that affects the innate immune system, resulting in increased susceptibility to fungal infections. We describe progressive dissemi-
nated phaeohyphomycosis due to a melanized fungus in a 26-year-old healthy female with inherited CARD9 deficiency to highlight
the clinical presentation of this disorder.
Case Presentation: The diagnosis of disseminated phaeohyphomycosis due to melanized fungi was made on the basis of clinical
and histopathological findings. CARD9gene was sequenced and a homozygous c.883C>T mutation in exon 6 at codon 295 was found,
resulting in a mutation at position 295, Q295X.
Conclusions: There are more cases of fungal infection associated with CARD9 deficiency in Iran compared to other Asian countries.
Although consanguineous marriage is common in the Middle East, severe fungal infections related to CARD9 deficiency were only
reported from Iran and Turkey. The higher incidence in comparison to other Middle Eastern countries may be associated with rapid
population growth, large family size, and the availability of diagnostic facilities. Although Iranian patients with Q295X mutation
are susceptible to candidiasis and dermatophytosis, our patient is the first report of phaeohyphomycosis related to Q295 mutation.
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1. Introduction
The caspase recruitment domain containing protein
9 (CARD9) deficiency is a primary immunodeficiency dis-
order affecting the innate immune system, resulting in
increased susceptibility to fungal infections (1). The in-
nate immune system is the first line of defense against
a wide spectrum of fungal pathogens and initiates the
production of cytokines by polymorphonuclears (PMNs),
which leads to a Th1/Th17 cell response (2-4). Several C-type
lectin receptors (CLRs) including, dectin-1, dectin-2, and
macrophage-inducible C-type lectin (Mincle) lead to the ac-
tivation of NF-κB family of transcriptional factors through
Syk or CARD9 pathways for cytokine production (5).
Mutations in numerous key genes involved in CLR sig-
naling pathways have been demonstrated to cause pri-
mary immunodeficiencies in humans (6). CARD9 is essen-
tial for signal transduction in CLR pathways. Analysis of
a murine Card9-/- model showed a loss of function mu-
tation that impairs innate signaling from the antifungal
pattern recognition receptor that identifies the β-glucan
component of fungal cell walls (7). CARD9 deficiencies
are clinically indistinguishable and patients with CARD9
defects are susceptible to recurrent and severe fungal in-
fections, including chronic mucocutaneous candidiasis
(CMC), dermatophytosis, phaeohyphomycosis, aspergillo-
sis, and protothecosis (3, 8-12). We described progressive
disseminated phaeohyphomycosis caused by a melanized
fungus in a 26-year-old previously healthy female with in-
herited CARD9 deficiency to highlight one presentation of
this disorder.
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2. Case Presentation
A 26-year-old healthy Iranian female was admitted to
the Department of Infectious Diseases, Tehran University
of Medical Sciences, Tehran, Iran, with cutaneous lesions
and localized dermatitis affecting the neck and face (Fig-
ure 1A and 1B). A singular, well-defined lesion with pu-
rulent secretions had developed gradually over a period
of eight years. The initial diagnosis was sarcoidosis at
that time and empirical treatment with a steroid (triam-
cinolone (4 mg/day)) was started for one month during
the hospitalization. The infection deteriorated leading to
severe dissemination of lesions to the skin of face, chest,
and legs. Skin biopsies examined in KOH 10% showed sep-
tate and pigmented hyphae, but no muriform cells or gran-
ules (hallmark of chromoblastomycosis and mycetoma, re-
spectively).
Despite surgical excision and antifungal therapy, the
number of the lesions increased nine months prior to ad-
mission (Figure 1A and 1B). On admission, full blood anal-
ysis revealed Hb 10.5 g/dl, WBC 17,100/mm3, RBC 3.2 ×
106/mm3, HCT 23.7%, MCV 73.37 fL, MCH 23.22 pg, RBC ratio
to Hb: 1/3, and MCHC 31.65 g/L. Serum electrolytes and liver
functions were within normal ranges. In addition, HIV and
hepatitis C antibodies were negative. There were no clini-
cal signs and symptoms of neurological involvement. The
patient did not remember any history of trauma or punc-
ture at the sites of infection.
The tissue samples were inoculated onto Sabouraud
Dextrose Agar (SDA, Difco) and brain heart infusion agar
with 5% sheep blood (BHI; Oxoid Ltd., Basingstoke, Hamp-
shire, England) and incubated at 27°C and 37°C for two
weeks in the dark but cultures remained negative. Other
biopsies prepared for histopathology showed a granulo-
matous infiltrate with irregular branched and melanized
septated hyphae (Figure 1C). The diagnosis of severe fungal
infection due to melanized fungi was made on the basis of
the clinical and histopathological findings.
Treatment with intravenous amphotericin B deoxy-
cholate (0.5 mg/kg/day) combined with oral voriconazole
(400 mg/day) was started. However, her condition deterio-
rated rapidly with aphasia, dysphoria, and a worsening of
the right limb weakness. Due to the absence of immuno-
suppressive conditions, treatment failure with potent an-
tifungal drugs, and history of consanguineous marriage,
a primary or secondary immune dysfunction was consid-
ered. Written informed consent was obtained from the pa-
tient’s next of kin for whole exome sequencing. Genomic
DNA was extracted from peripheral venous blood samples
using the Gentra Puregene Blood DNA isolation kit (Qia-
gen, Hilden, Germany) according to the manufacturer’s in-
structions. Polymerase chain reaction (PCR) amplification
and sequencing were performed by Sanger sequencing on
an ABI 3730 DNA sequencer (Applied Biosystems, Torrance,
California, USA). A homozygous c.C883T mutation in exon 6
at codon 295, a nonsense variant (Q295X) was identified.
Ultimately, despite combination antifungal therapy,
the patient died 38 days after admission because of respi-
ratory failure. No therapeutic drug monitoring was per-
formed. To obtain an etiological diagnosis, DNA was ex-
tracted from a formalin-fixed paraffin-embedded tissue us-
ing the tissue DNA isolation kit (Qiagen) according to the
manufacturer’s instructions. PCR amplification and se-
quencing were performed for ITS rDNA and D1/D2 regions
(9), but due to the lack of sufficient tissue for examination,
we failed to identify the cause of the phaeohyphomycosis
despite extensive efforts.
3. Discussion
Inherited CARD9 deficiency is a well-known primary
immunodeficiency disease, which leads to defects in anti-
fungal defense mechanisms. Unusual and severe fungal in-
fections can be a sign or complication of CARD9 deficiency.
It commonly presents with deep dermatophytosis and in-
vasive Candida infections (8, 10). This study described a
case of progressive disseminated phaeohyphomycosis in
a 26-year-old healthy woman with a nonsense Q295X mu-
tation (c.883C>T) in the caspase recruitment domain pro-
tein. There are more reported cases of fungal infection
with CARD9 deficiency from Iran (n = 10) than from other
Asian countries (9, 13, 14, 15). The total number of Iranian
patients has been summarized in Table 1.
Consanguineous marriages may be the reason for the
high prevalence of CARD9 deficiencies in Iran. Although
consanguineous marriages are common in the Middle East
(16), severe fungal infections related to CARD9 deficiency
were only reported from Iran and Turkey (13, 14). The higher
incidence of this immunodeficiency with fungal infection
in comparison to other Middle Eastern countries might be
associated with rapid population growth, large family size,
and the availability of diagnostic facilities.
The homozygous nonsense mutation, Q295X, is the
most frequent among Iranian patients (n = 8, 80 %). Al-
though Iranian patients with the Q295X mutation are
highly susceptible to candidiasis (n = 7) and dermatophy-
tosis (n = 3), our patient is the first report of phaeohy-
phomycosis related to Q295 mutation. The relationship be-
tween CARD 9 mutations and fungal infections is impor-
tant in better understanding the pathogenic mechanisms
underlying these infections. Severe opportunistic fungal
infections are a major cause of mortality in patients with
primary immunodeficiency disease. Therefore, patients
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Figure 1. A and B, Clinical manifestation of the current case; C, a granulomatous infiltrate with irregular, branched and melanized septated hyphae (hematoxylin and eosin
(H and E),× 400)
Table 1. Overview of 10 Reported Cases of Severe Fungal Infection Related to CARD9 Deficiency
No. Age/Sex Year Fungal Infection Length of Infection Causative Agent(s) Nucleotide Change Amino Acid Change Treatment Clinical Evolution Reference
1 19/M 2009 Oral candidiasis 16 y Candida albicans c.883C>T HMZ Q295X KCZ Cured (9)
2 19/M 2009 Candida meningitis 18 y Candida albicans c.883C>T HMZ Q295X - Died
3 50/F 2009 Vaginal candidiasis,
dermatophytosis
8 y, 5 y Candida albicans,
Dermatophyte spp.
c.883C>T HMZ Q295X - -





c.883C>T HMZ Q295X - Cured
5 -/M 2009 Dermatophytosis - - c.883C>T HMZ Q295X - Cured
6 15/F 2009 Chronic and invasive
candidiasis
-, 2 y - c.883C>T HMZ Q295X - Died
7 15/F 2009 Chronic candidiasis and
Candida
meningoencephalitis
-, 0.5 y - c.883C>T HMZ Q295X - Died
8 26/F 2015 Disseminated
phaeohyphomycosis
8 y Exophiala spinifera c.GAG967-969del HMZ E323del - Cured (13)
9 28/M 2015 Meningoencephalitis 11 y Candida glabrata c.G104A HMZ R35Q FCZ, ICZ Cured (14)
10 26/F - Disseminated
phaeohyphomycosis
8 y Melanized fungus c.883C>T HMZ Q295X VCZ, AMB Died Current case
Abbreviations: AmB, amphotericin B; FCZ, fluconazole; HMZ, homozygote; ICZ, itraconazole; KCZ, ketoconazole; VCZ, voriconazole; (-) not describe.
with prolonged or severe fungal infections without other
explanations should be evaluated for CARD9 mutations.
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